How Researchers Describe Its Mechanism In research settings, AOD 9604 has been studied for its proposed role in lipolysis, the breakdown of stored fat
Protocol: AOD 9604: 500mcg morning fasted Semaglutide: Standard titration protocol (start low, increase gradually) This combination requires closer monitoring since you're affecting multiple metabolic pathways
As of June 2026, the FDA's December 2024 Pharmacy Compounding Advisory Committee evaluation concluded that the criteria weighed against placing AOD-9604 (free base) or AOD-9604 acetate on the 503A Bulks List, and AOD-9604 is currently listed as Nominated but Withdrawn from FDA Category 2
PubMed 22962027 TB-4 Phase 1 human safety first-in-human randomized, double-blind, single- and multiple-dose Phase 1 of recombinant human thymosin 4 in healthy volunteers, no serious adverse events: PubMed 34346165
AOD 9604 is one specific blade from that knife, doing one job extremely well without the complications
You still need a caloric deficit